Using GLP-1s

Lowest effective dose

The prescribing principle of using the smallest dose that achieves the treatment goal with acceptable side effects — which for GLP-1s is often below the maximum dose on the label.

By the glp1.how editorial teamReviewed Sep 2, 2026

"Lowest effective dose" is a general principle in prescribing: use the smallest amount of a medication that reliably achieves the treatment goal, because side effects usually scale with dose while benefits often plateau. It is the reason GLP-1 medications are titrated up in steps rather than started at full strength, and the reason many people stop climbing before the top dose on the label.

For GLP-1s, the goal might be blood sugar control, a satisfactory pace of weight loss, or holding weight steady in maintenance. If that is achieved at 1 mg of semaglutide or 5 mg of tirzepatide with manageable side effects, there is often no clinical reason to go higher, and the ADA's guidance explicitly makes this point. Staying at a lower dose that works is a legitimate outcome. See what "maintenance dose" actually means and why some people stay on a lower maintenance dose.

The ADA's 2026 obesity medication standards say the individualized maintenance dose "should balance efficacy, health benefits, and tolerability and therefore may not necessarily be the maximum approved dose" (BMJ Open Diabetes Research & Care (external link)).

dosinglowest-effective-dosemaintenance-doseside-effects

Revision history

Updated 2 times since Sep 2, 2026 · show changes

v3Sep 26, 2026, 12:57 AM CDT
Body revised
v2Sep 26, 2026, 12:02 AM CDT
Body revised; Metadata updated
v1Sep 1, 2026, 9:39 PM CDT
Change tracking began

Related guides

Shot day routines: how the GLP-1 community builds a weekly injection ritual · Once-weekly dosing turns "shot day" into a small ritual. People build routines around it: picking the right day, warming the pen to reduce sting, rotating sites, eating lighter, logging everything, and heading off side effects before they start. This is a tour of the common routines GLP-1 users swear by, and the reasons behind the ones worth copying.
Tapering vs. staying on a maintenance dose for long-term use · Long-term GLP-1 treatment doesn't have to mean staying at your highest effective dose indefinitely. This guide compares tapering to a lower maintenance dose with stopping altogether or holding steady.
When and why a prescriber might slow down your titration · You can stay at a dose step longer than the standard titration schedule says. This guide covers what the labels allow, the common reasons prescribers extend a step, and how to raise it.
Why some people stay on a lower maintenance dose · Staying below the maximum labeled dose isn't a compromise or a sign of "not trying hard enough." For many people it's the clinically appropriate outcome. The reasons, and what the trials show about lower doses.
What "maintenance dose" actually means and how it's decided · Your maintenance dose is the dose that works for you, which isn't always the highest dose on the label. This guide explains how that dose gets chosen, what the trials show about higher and lower maintenance doses, and when it can change.
Gastric emptying on a GLP-1: how much slower, how long it lasts, and what it means for gastroparesis · GLP-1 medications slow the stomach, but the trials show the effect is smaller and fades more than most people assume, especially with the long-acting weekly drugs. This guide covers how much slower, whether it lasts, how gastric emptying is measured, how it differs from gastroparesis, and why the "food ferments in your stomach" claim has no evidence behind it.

Related terms

GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
Tirzepatide · A once-weekly dual GIP and GLP-1 receptor agonist made by Eli Lilly, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management and obstructive sleep apnea.
Semaglutide · A GLP-1 receptor agonist medication made by Novo Nordisk, sold under the brand names Ozempic (type 2 diabetes) and Wegovy (weight management), each as an injection or a pill.
Maintenance dose · The stable, ongoing dose taken once titration is complete, intended to sustain treatment effects long-term.
Efficacy · How well a medication performs under ideal, controlled conditions — typically measured in clinical trials.

Was this helpful?

Improve this page